<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00221871</url>
  </required_header>
  <id_info>
    <org_study_id>UHN02-0233-A</org_study_id>
    <nct_id>NCT00221871</nct_id>
  </id_info>
  <brief_title>Proper Dosage of Ketamine in Intravenous Regional Anesthesia</brief_title>
  <official_title>Proper Dosage of Intravenous Ketamine When Used as an Adjuvant to Lidocaine in Intravenous Regional Anesthesia (IVRA).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Health Network, Toronto</source>
  <brief_summary>
    <textblock>
      Ketamine added to Lidocaine can increase duration of pain relief following intraveonous
      regional anesthesia (IVRA). The purpose of this dose response study is to determine the
      minimum effective dosage of intravenous Ketamine, added to 3 mg/kg of Lidocaine. We
      anticipate that one dosage will provide us with the proper balance between sufficient
      anesthesia and minimal side effects.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2004</start_date>
  <completion_date>January 2005</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single</masking>
  </study_design_info>
  <condition>Pain.</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Different dosages of Ketamine</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age: 18-70

          2. Weight: 50-100 kg

          3. ASA: I, II, III

          4. Carpal tunnel syndrome surgery, tenolysis, ganglion removal or any peripheral hand
             surgery that can be done by IVRA.

        Exclusion Criteria:

          1. Contraindication to IVRA such as sickle cell disease.

          2. Any known hypersensitivity reaction to Ketamine.

          3. History of chronic pain or regular medication with analgesics.

          4. History of opioid dependence.

          5. Drug of alcohol abuse.

          6. Psychiatric disorder.

          7. Allergy to acetaminophen or codeine
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Colin McCartney, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Health Network, Toronto</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Colin McCartney, MD</last_name>
    <phone>(416)603-5118</phone>
    <email>colin.mccartney@uhn.on.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Health Network</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5T2S8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Filomena Valle-Leutri, BSc</last_name>
      <phone>(416)603-5800</phone>
      <phone_ext>2016</phone_ext>
      <email>filomena.valle-leutri@uhn.on.ca</email>
    </contact>
    <investigator>
      <last_name>Colin McCartney, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vincent Chan, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Philip Peng, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paul Tumber, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 20, 2005</study_first_submitted>
  <study_first_submitted_qc>September 20, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2005</study_first_posted>
  <last_update_submitted>October 10, 2006</last_update_submitted>
  <last_update_submitted_qc>October 10, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 11, 2006</last_update_posted>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

